Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Clin-e-cal
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Idea== Clin-e-cal started with our founder, Tariq Aslam, solving problems he had giving inhaler medication to his young son - Rafi. He realised his wasn’t a unique problem and Rafi-Tone, the solution he developed, had the potential to help many children using inhalers with a spacer. Since launching in 2016, the app, powered by our patented Sound Response engine, has had thousands of downloads across the UK, Australia, and Scandinavia. We are now planning to advance the sound analysis technology to address problems in inhaler users of all ages. Currently undergoing beta testing, the first version of our new Clip-Tone Buddy app uses sound analysis to give real-time feedback, helping patients understand how to use their inhalers correctly. We have estimated a £300m near-term addressable opportunity and we are targeting pharma companies and inhaler manufacturers directly to build the user base and develop real-world insights. We believe these insights can help transform care, providing healthcare professionals with detailed information on patients’ inhaler use. We strive for our data to ultimately help streamline clinical trials, identify patients most at risk and impact future respiratory device design. We are raising now to progress commercialisation of the Clip-Tone Buddy, scale the sales activity and for additional support in marketing, regulatory and legal aspects of the business.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)